Biopsy Guidance System Market is projected to reach a valuation of US$ 2 Billion by 2032

 According to Future Market Insights’ newly released Biopsy Guidance System Market analysis report, global sales of the Biopsy Guidance System Market in 2021 were held at US$ 1.1 Billion. The market is expected to reach a valuation of US$ 2 billion by 2032, with a CAGR of 5.8% between 2022 and 2032. Stereotactic Guided Biopsy is expected to be the highest revenue-generating segment, growing at a CAGR of 6.1% between 2022 and 2032.

Get Full Access @ https://www.futuremarketinsights.com/reports/biopsy-guidance-system-market

According to Future Market Insights, a supplier of market research and competitive data, the market value of the Biopsy Guidance System Market increased historically between 2017 and 2021 at a CAGR of roughly 5.1%.


The primary factors driving the market include the rising incidence of cancer, the ageing population, the increased desire for minimally invasive procedures, technical advancements, and government efforts. Breast, brain, skin, and prostate cancers are among the chronic conditions for which a biopsy is one of the most often utilised diagnostic techniques.

Biopsy Navigation System is a medical device that assists physicians in obtaining tissue samples from a patient’s body for diagnostic purposes. The system includes imaging technology such as ultrasound, MRI, or CT scans to locate the tissue that needs to be sampled, and a needle or other device that is used to extract the tissue.

FMI, in its business report, elaborates the historical and current scenario of the global Biopsy Guidance System market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Why Choose Future Market Insights

  • Serving domestic and international clients 24/7
  • Prompt and efficient customer service
  • Data collected from reliable primary and secondary sources
  • Highly trained and experienced team of research analysts
  • Seamless delivery of tailor-made market research reports

Key Companies Profiled:

  • Becton, Dickinson, and Company
  • Hologic, Inc.
  • Devicor Medical Products, Inc.
  • B. Braun Melsungen AG
  • ARGON MEDICAL
  • Boston Scientific Corporation
  • INRAD Inc.
  • Cook Medical
  • PLANMED OY

Key Offerings of the Report

  • Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
  • Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
  • Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
  • Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
  • Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Biopsy Guidance System market

Market Segments Covered in Biopsy Guidance System Market Analysis

By Product Type:

  • Stereotactic Guided Biopsy
  • Ultrasound Guided Biopsy
  • MRI Guided Biopsy

By Application:

  • Brain Biopsy
  • Breast Biopsy
  • Other Applications

By End-User:

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centres
  • Research and Academic Institutes

Comments

Post a Comment

Popular posts from this blog

Pet Diabetes Care Devices Market Report | Size, Growth, Demand, Scope and Forecast to 2032

  The global  Pet Diabetes Care Devices Market  is expected to grow at a  6.5%  CAGR, reaching  US$ 4 billion  by 2032, up from  US$ 2 billion  in 2021. “The number of pets with diabetes, the number of adopted pets, and the number of overweight pets are all driving the market forward.” Get Full Access @ https://www.futuremarketinsights.com/reports/pet-diabetes-care-devices-market The domestication of animals is leading to a lack of insulin production in them. The limited flow of glucose to the cell can be termed diabetes. This chronic disease is a major concern for pet owners and needs to be taken care of. This concern leads to the expansion of the pet diabetes care devices market. Devices like the alphatrak blood glucose meter are in use as they help the pet owners monitor the pet’s health. The increased number of people adopting pets and then domesticating them around in their households, treating and caring for them as f...
Read more

Human Immunodeficiency Virus Type 1 (HIV 1) Market Opportunity, Competitive Analysis, Future Prospects to 2033

Image
  The global Human Immunodeficiency Virus Type 1 (HIV 1) Market is predicted to exceed a remarkable valuation of US$ 34.83 Billion in 2023, with a compound annual rate of growth (CAGR) of 6% estimated from 2023 to 2033. The Institute for Health Metrics and Evaluation attributes the industry's growth to the soaring incidence rate of HIV-1 infection, which, unlike the deaths caused from this viral illness, has not updated substantially over time. Get Full Access @ https://www.futuremarketinsights.com/reports/human-immunodeficiency-virus-type-1-hiv1-market It affected approximately 37 million people worldwide. Furthermore, antiretroviral therapeutic interventions for disease management are only available to half of this population. HIV-1 is the more common of the two types of human immunodeficiency virus, accounting for approximately 96% of all infections globally. The prevalence of HIV is rising at an alarming rate. The World Health Organization (WHO) estimates that 33.0 million...
Read more

Clostridium Diagnostics Market in US is anticipated to secure a market value worth US$ 2.7 Billion by 2032 | FMI

Image
  The global Clostridium Diagnostics Market is expected to grow at a CAGR of 12.2% during the forecast period, from US$ 2.5 billion in 2022 to US$ 7.8 billion by 2032. The market grew at a CAGR of 13.6% between 2015 and 2021. The rising prevalence of clostridium-related diseases, as well as increased campaigns to educate people about the condition, are driving the market growth. To learn more about this report @ https://www.futuremarketinsights.com/reports/clostridium-diagnostics-market here has been an increased focus of players in the market to offer vaccines, which can augment the market size in the forecast period. For instance, in March 2022, Japan launched a new center, with a budget of US$ 1.6 Billion, to support vaccine and drug projects as a part of a larger scheme to tackle infectious diseases. SCARDA will be in charge of establishing a flagship R&D site for innovative collaborations and controlling funds for R&D projects. Awareness camp...
Read more